Paradigm Capital Management Inc. NY continued to hold its position in Nu Skin Enterprises, Inc. (NYSE:NUS) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,000 shares of the company’s stock at the end of the first quarter. Paradigm Capital Management Inc. NY’s holdings in Nu Skin Enterprises were worth $278,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of NUS. AQR Capital Management LLC raised its position in Nu Skin Enterprises by 28.8% in the fourth quarter. AQR Capital Management LLC now owns 1,664,001 shares of the company’s stock valued at $79,506,000 after buying an additional 372,166 shares during the period. Dimensional Fund Advisors LP raised its position in Nu Skin Enterprises by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 947,226 shares of the company’s stock valued at $45,260,000 after buying an additional 39,926 shares during the period. State Street Corp raised its position in Nu Skin Enterprises by 2.4% in the fourth quarter. State Street Corp now owns 802,056 shares of the company’s stock valued at $38,321,000 after buying an additional 18,471 shares during the period. Bank of New York Mellon Corp raised its position in Nu Skin Enterprises by 91.5% in the first quarter. Bank of New York Mellon Corp now owns 724,762 shares of the company’s stock valued at $40,253,000 after buying an additional 346,236 shares during the period. Finally, Norges Bank bought a new position in Nu Skin Enterprises during the fourth quarter valued at about $27,260,000. Institutional investors own 78.88% of the company’s stock.
Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 0.63% during midday trading on Friday, reaching $55.90. The company’s stock had a trading volume of 407,487 shares. Nu Skin Enterprises, Inc. has a 12-month low of $38.19 and a 12-month high of $66.04. The stock’s 50-day moving average price is $55.59 and its 200-day moving average price is $52.72. The company has a market cap of $2.95 billion, a P/E ratio of 18.55 and a beta of 1.66.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, May 3rd. The company reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.01. Nu Skin Enterprises had a return on equity of 20.06% and a net margin of 6.26%. The business had revenue of $499.10 million for the quarter, compared to the consensus estimate of $493.65 million. During the same quarter in the prior year, the business posted $0.42 EPS. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, analysts expect that Nu Skin Enterprises, Inc. will post $3.12 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 14th. Investors of record on Friday, May 26th will be given a $0.36 dividend. The ex-dividend date is Wednesday, May 24th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.59%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 57.96%.
NUS has been the topic of several analyst reports. Zacks Investment Research lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, May 6th. Sidoti lowered Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price on the stock. in a research note on Wednesday, April 26th. Jefferies Group LLC set a $52.00 target price on Nu Skin Enterprises and gave the company a “hold” rating in a research note on Friday, February 17th. Deutsche Bank AG reiterated a “buy” rating and issued a $63.00 target price on shares of Nu Skin Enterprises in a research note on Sunday, February 19th. Finally, Pivotal Research reissued a “buy” rating and issued a $65.00 price target on shares of Nu Skin Enterprises in a report on Thursday, May 4th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $59.00.
In related news, General Counsel D Matthew Dorny sold 16,000 shares of the company’s stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $50.00, for a total value of $800,000.00. Following the completion of the sale, the general counsel now directly owns 45,730 shares of the company’s stock, valued at approximately $2,286,500. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last three months, insiders sold 32,000 shares of company stock valued at $1,708,960. Insiders own 4.60% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.